22 Mar 2011
Clariant Masterbatches appoints regulatory and ISO 13485 expert to Medical and Pharmaceutical team
Muttenz, 22 March 2011 – Clariant Masterbatches reaffirms its commitment to the unique needs of its medical device and pharmaceutical packaging customers with the appointment of a dedicated global regulatory and ISO 13485 manager to its new Medical and Pharmaceutical segment.
22 Mar 2011
Bringing Distinctive Style to Medical Devices While Ensuring Safety, Regulatory Compliance
In today’s competitive marketplace manufacturers must try to differentiate their product from others by improving functionality and design. Use of drug delivery devices increasingly occurs outside of a hospital setting and since it is the patient rather than a doctor who is the user, the device must be attractive as well as convenient and functional. They become more like any other consumer product. That’s why color and other visual elements are increasingly important in device design.
22 Mar 2011
Clariant International Ltd Press Kit Medtec 2011
Clariant Masterbatches presents the latest in its MEVOPUR® color masterbatches and custom performance compounds designed to bring cutting-edge functionality and aesthetics to medical devices and pharmaceutical packaging at Medtec 2011.
21 Mar 2011
Aviation de-icing acquisition to expand Clariant’s North American capabilities
Clariant acquires Octagon Process LLC
Transaction benefits include expanded geographic footprint, improved reliability of supply, logistical and sourcing strengths
Expansion complements companies’ existing business, offers growth in “greener” deicing alternatives and enhanced technological innovation
Terms of transaction not disclosed
9 Mar 2011
Users of Advanced Medical Polymers Gain Controlled, Consistent, Compliant Color With New Clariant MEVOPUR® Masterbatches
Muttenz, 9 March 2011 – Manufacturers of medical devices and packaging who choose newer plastic materials like Eastman Tritan™ co-polyester and TOPAS® cyclic olefin copolymer (COC) now have readily available color options that are pretested and compliant with key standards governing materials used in medical and pharmaceutical applications. Available under the new Clariant Masterbatches brand name MEVOPUR®, these color concentrates and pre-color compounds are produced under specially controlled conditions in ISO13485 certified plants, using raw materials that have been biologically evaluated against USP parts 87 and 88 (Class VI devices) and/or the international standard ISO10993, and spectroscopically analyzed on delivery.
4 Mar 2011
Protection – be safe and be certain – the technical textiles industry can count on Clariant
Muttenz, 24 May 2011 – ‘Performance that protects – Protection that performs’ is Clariant’s key theme for the 2011 Techtextil show.
2 Mar 2011
Clariant Oil Services to Launch VeriTrax® at CORROSION 2011
Houston, Texas (USA), 02 March 2011 – Specialty chemicals expert Clariant’s Oil Services business will introduce its VeriTrax® Automated Data Exchange system, an integrated chemical delivery and data management system for providing production chemicals to the oil and gas industry, at NACE CORROSION 2011 at the George R. Brown Convention Center in Houston, Texas, March 13-17, 2011.
23 Feb 2011
Clariant Masterbatches Establishes Dedicated Medical and Pharmaceutical Global Segment
Muttenz, 23 February 2011 – Clariant has established a global Medical and Pharmaceutical segment within its Masterbatches Business Unit to further strengthen its dedicated support for customers in these highly-demanding markets.
23 Feb 2011
Clariant’s Masterbatches Business increases prices
Muttenz, 23 February 2011 – The Masterbatches Business Unit of Clariant, a leading masterbatches player globally, announces global price increases for most of its products.
21 Feb 2011
Clariant’s Pigments Business increases prices
Muttenz, 21 February 2011 – Clariant's Business Unit Pigments, a world leader in organic pigments and dyes, announces price increases across its product portfolio.
16 Feb 2011
Clariant plans acquisition of Süd-Chemie AG
• Accelerating profitable growth
• Addition of future technologies with high growth potential
• Enterprise value of EUR 2.0 billion (CHF 2.5 billion)
• Family shareholders convert Süd-Chemie shares into Clariant shares
16 Feb 2011
Clariant successfully completes restructuring in 2010; profitability to further improve in 2011
• Full-year sales up 13% in local currency and 8% in CHF
• Operating income margin before exceptional items of 9.8% compared to 4.1% in 2009
• Cash flow from operations of CHF 642 million after CHF 757 million in the previous year
• Net debt reduced from CHF 545 million in 2009 to CHF 126 million
• Net income amounted to CHF 191 million compared to a net loss of CHF 194 million in 2009
• 2011 Outlook: Clariant expects a stable business environment in 2011, with growth mainly coming from the emerging markets. Based on this scenario, Clariant forecasts local currency sales growth in the low single-digit range and an EBITDA margin before exceptional items above that of 2010.
